In recent years, drugmakers have raised prices on dozens of brand-name medicines at a pace that outstrips inflation, Bloomberg News reportstoday. The accompanying graphic shows that the cost of one drug in particular -- Xyrem, a narcolepsy treatment from Jazz Pharmaceuticals -- has climbed more than 840 percent since 2007.
So the Trade of the Day is to buy Xyrem and stockpile it in your medicine cabinet -- just in case.
This column does not necessarily reflect the opinion of Bloomberg View's editorial board or Bloomberg LP, its owners and investors.
To contact the author on this story:
Mark Gilbert at firstname.lastname@example.org
To contact the editor on this story:
James Greiff at email@example.com